Supported by the National Basic Research Program of China (973 Program,No.2003CB517103);the Natural Science Foundation of Beijing(No.7062058)
The existing efficacy evaluation for coronary heart disease (CHD) angina pectoris does not demonstrate the characteristics and advantages of Chinese medicine (CM), so a new system of efficacy evaluation which can ...
Supported by the Major State Basic Research Development Program of China(973 Program,No.2003CB517103);the National Medical Science and Technique Foundation during the 10th Five-Year Plan Period(No.2004BA721A01HO9);the National Natural Science Foundation of China(No.90209011)
Objective: To observe the effect of Chinese medicine Shenshao Tablet (参芍片, SST) on the quality of life in coronary heart disease (CHD) patients with stable angina pectoris (SAP). Methods: Sixty-six patients...